Deletion of Glut1 in early postnatal cartilage reprograms chondrocytes toward enhanced glutamine oxidation

Abstract

Glucose metabolism is fundamental for the functions of all tissues, including cartilage. Despite the emerging evidence related to glucose metabolism in the regulation of prenatal cartilage development, little is known about the role of glucose metabolism and its biochemical basis in postnatal cartilage growth and homeostasis. We show here that genetic deletion of the glucose transporter Glut1 in postnatal cartilage impairs cell proliferation and matrix production in growth plate (GPs) but paradoxically increases cartilage remnants in the metaphysis, resulting in shortening of long bones. On the other hand, articular cartilage (AC) with Glut1 deficiency presents diminished cellularity and loss of proteoglycans, which ultimately progress to cartilage fibrosis. Moreover, predisposition to Glut1 deficiency severely exacerbates injury-induced osteoarthritis. Regardless of the disparities in glucose metabolism between GP and AC chondrocytes under normal conditions, both types of chondrocytes demonstrate metabolic plasticity to enhance glutamine utilization and oxidation in the absence of glucose availability. However, uncontrolled glutamine flux causes collagen overmodification, thus affecting extracellular matrix remodeling in both cartilage compartments. These results uncover the pivotal and distinct roles of Glut1-mediated glucose metabolism in two of the postnatal cartilage compartments and link some cartilage abnormalities to altered glucose/glutamine metabolism.

References

[1] Pacifici M, Koyama E, Iwamoto M. Mechanisms of synovial joint and articular cartilage formation: recent advances, but many lingering mysteries. Birth Defects Res. C. Embryo Today, 2005, 75: 237-248

[2] Zuscik MJ, Hilton MJ, Zhang X, Chen D, O’Keefe RJ. Regulation of chondrogenesis and chondrocyte differentiation by stress. J. Clin. Investig., 2008, 118: 429-438

[3] Kronenberg HM. Developmental regulation of the growth plate. Nature, 2003, 423: 332-336

[4] Tsang KY, Tsang SW, Chan D, Cheah KS. The chondrocytic journey in endochondral bone growth and skeletal dysplasia. Birth Defects Res. C. Embryo Today, 2014, 102: 52-73

[5] Goldring MB. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther. Adv. Musculoskelet. Dis., 2012, 4: 269-285

[6] Zhang L, Hu J, Athanasiou KA. The role of tissue engineering in articular cartilage repair and regeneration. Crit. Rev. Biomed. Eng., 2009, 37: 1-57

[7] Shen J, Abu-Amer Y, O’Keefe RJ, McAlinden A. Inflammation and epigenetic regulation in osteoarthritis. Connect Tissue Res., 2017, 58: 49-63

[8] Wang M et al. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann. N. Y. Acad. Sci., 2011, 1240: 61-69

[9] Kreitz J et al. Metabolic plasticity of acute myeloid leukemia. Cells, 2019, 8: 805

[10] Muschen M. Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation. Nat. Rev. Immunol., 2019, 19: 337-348

[11] Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat. Rev. Mol. Cell Biol., 2019, 20: 436-450

[12] Lee WC, Guntur AR, Long F, Rosen CJ. Energy metabolism of the osteoblast: implications for osteoporosis. Endocr. Rev., 2017, 38: 255-266

[13] Heywood HK, Knight MM, Lee DA. Both superficial and deep zone articular chondrocyte subpopulations exhibit the Crabtree effect but have different basal oxygen consumption rates. J. Cell Physiol., 2010, 223: 630-639

[14] Pollesello P et al. Energy state of chondrocytes assessed by 31P-NMR studies of preosseous cartilage. Biochem. Biophys. Res. Commun., 1991, 180: 216-222

[15] Wei J et al. Glucose uptake and Runx2 synergize to orchestrate osteoblast differentiation and bone formation. Cell, 2015, 161: 1576-1591

[16] Lee SY, Abel ED, Long F. Glucose metabolism induced by Bmp signaling is essential for murine skeletal development. Nat. Commun., 2018, 9

[17] Wang J, Zhou J, Bondy CA. Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J., 1999, 13: 1985-1990

[18] Esen E, Lee SY, Wice BM, Long F. PTH promotes bone anabolism by stimulating aerobic glycolysis via IGF signaling. J. Bone Min. Res., 2015, 30: 2137

[19] Uchimura T et al. An essential role for IGF2 in cartilage development and glucose metabolism during postnatal long bone growth. Development, 2017, 144: 3533-3546

[20] Mobasheri A et al. The role of metabolism in the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol., 2017, 13: 302-311

[21] Tchetina EV, Markova GA. Regulation of energy metabolism in the growth plate and osteoarthritic chondrocytes. Rheumatol. Int, 2018, 38: 1963-1974

[22] Wang C, Silverman RM, Shen J, O’Keefe RJ. Distinct metabolic programs induced by TGF-beta1 and BMP2 in human articular chondrocytes with osteoarthritis. J. Orthop. Transl., 2018, 12: 66-73

[23] Shen J et al. DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism. JCI Insight, 2017, 2: e93612

[24] Rosa SC et al. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res. Ther., 2009, 11: R80

[25] Mobasheri A et al. Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis. Histol. Histopathol., 2002, 17: 1239-1267

[26] Shikhman AR, Brinson DC, Valbracht J, Lotz MK. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J. Immunol., 2001, 167: 7001-7008

[27] Fendt SM et al. Reductive glutamine metabolism is a function of the alpha-ketoglutarate to citrate ratio in cells. Nat. Commun., 2013, 4

[28] Gameiro PA et al. In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. Cell Metab., 2013, 17: 372-385

[29] Stegen S et al. HIF-1alpha metabolically controls collagen synthesis and modification in chondrocytes. Nature, 2019, 565: 511-515

[30] Annunen P, Autio-Harmainen H, Kivirikko KI. The novel type II prolyl 4-hydroxylase is the main enzyme form in chondrocytes and capillary endothelial cells, whereas the type I enzyme predominates in most cells. J. Biol. Chem., 1998, 273: 5989-5992

[31] Myllyharju J, Kivirikko KI. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet, 2004, 20: 33-43

[32] Jarman-Smith ML et al. Porcine collagen crosslinking, degradation and its capability for fibroblast adhesion and proliferation. J. Mater. Sci. Mater. Med., 2004, 15: 925-932

[33] Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem., 2003, 278: 30772-30780

[34] Gilkes DM et al. Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells. Proc. Natl Acad. Sci. USA, 2014, 111: E384-E393

[35] Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009, 324: 1029-1033

[36] Hochachka PW, Buck LT, Doll CJ, Land SC. Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc. Natl Acad. Sci. USA, 1996, 93: 9493-9498

[37] Groesbeck DK, Bluml RM, Kossoff EH. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev. Med. Child Neurol., 2006, 48: 978-981

[38] Wilsman NJ, Farnum CE, Leiferman EM, Fry M, Barreto C. Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics. J. Orthop. Res, 1996, 14: 927-936

[39] Cooper KL et al. Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions. Nature, 2013, 495: 375-378

[40] Decker RS, Koyama E, Pacifici M. Articular cartilage: structural and developmental intricacies and questions. Curr. Osteoporos. Rep., 2015, 13: 407-414

[41] Martin JA et al. Mitochondrial electron transport and glycolysis are coupled in articular cartilage. Osteoarthr. Cartil., 2012, 20: 323-329

[42] Hitchcock AM, Yates KE, Shortkroff S, Costello CE, Zaia J. Optimized extraction of glycosaminoglycans from normal and osteoarthritic cartilage for glycomics profiling. Glycobiology, 2007, 17: 25-35

[43] Gavriilidis C, Miwa S, von Zglinicki T, Taylor RW, Young DA. Mitochondrial dysfunction in osteoarthritis is associated with down-regulation of superoxide dismutase 2. Arthritis Rheum., 2013, 65: 378-387

[44] Ruiz-Romero C et al. Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis. Proteomics, 2008, 8: 495-507

[45] Cantor JR, Sabatini DM. Cancer cell metabolism: one hallmark, many faces. Cancer Disco., 2012, 2: 881-898

[46] Yang C et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol. Cell, 2014, 56: 414-424

[47] Tohyama S et al. Glutamine oxidation is indispensable for survival of human pluripotent stem cells. Cell Metab., 2016, 23: 663-674

[48] Bolduc JA, Collins JA, Loeser RF. Reactive oxygen species, aging and articular cartilage homeostasis. Free Radic. Biol. Med., 2019, 132: 73-82

[49] Portron S et al. Effects of in vitro low oxygen tension preconditioning of adipose stromal cells on their in vivo chondrogenic potential: application in cartilage tissue repair. PLoS One, 2013, 8: e62368

[50] Jaakkola P et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 2001, 292: 468-472

[51] Young CD et al. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS One, 2011, 6: e23205

[52] Madisen L et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci., 2010, 13: 133-140

[53] Henry SP et al. Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage. Genesis, 2009, 47: 805-814

[54] Kamekura S et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthr. Cartil., 2005, 13: 632-641

[55] Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr. Cartil., 2010, 18: S17-S23

[56] Shen J et al. Inhibition of 4-aminobutyrate aminotransferase protects against injury-induced osteoarthritis in mice. JCI Insight, 2019, 4: e128568

[57] Jonason JH, Hoak D, O’Keefe RJ. Primary murine growth plate and articular chondrocyte isolation and cell culture. Methods Mol. Biol., 2015, 1226: 11-18

[58] Gosset M, Berenbaum F, Thirion S, Jacques C. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc., 2008, 3: 1253-1260

[59] Ivanisevic J et al. Toward ‘omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism. Anal. Chem., 2013, 85: 6876-6884

Funding

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)(U01CA235482)

U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(AR075860)